Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
39.50
-0.24 (-0.60%)
May 14, 2025, 10:01 AM - Market open

Apogee Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
106.92141.79118.32151.89
Short-Term Investments
406.41378.86277.14-
Cash & Short-Term Investments
513.33520.65395.46151.89
Cash Growth
-37.11%31.66%160.36%-
Other Receivables
5.014.71.21-
Receivables
5.014.71.21-
Prepaid Expenses
2.612.621.740.11
Other Current Assets
0.591.74-0.06
Total Current Assets
521.53529.71398.41152.06
Property, Plant & Equipment
17.1913.322.59-
Long-Term Investments
168.11210.42--
Other Long-Term Assets
7.340.50.4-
Total Assets
714.16753.95401.4152.06
Accounts Payable
2.451.072.140.42
Accrued Expenses
26.5424.2617.319.56
Current Portion of Leases
3.983.231.1-
Total Current Liabilities
32.9628.5620.569.98
Long-Term Leases
7.848.60.93-
Total Liabilities
40.837.1621.499.98
Common Stock
00-2.25
Additional Paid-In Capital
1,0341,022503.35-
Retained Earnings
-361.26-305.92-123.77-39.79
Comprehensive Income & Other
1.070.920.332.14
Total Common Equity
673.36716.79379.91-35.39
Shareholders' Equity
673.36716.79379.91142.08
Total Liabilities & Equity
714.16753.95401.4152.06
Total Debt
11.8211.832.03-
Net Cash (Debt)
669.62719.24393.43151.89
Net Cash Growth
-17.78%82.82%159.02%-
Net Cash Per Share
11.7113.0315.7361.69
Filing Date Shares Outstanding
58.3158.0948.525
Total Common Shares Outstanding
58.358.0648.525
Working Capital
488.57501.15377.85142.08
Book Value Per Share
11.5512.357.83-7.08
Tangible Book Value
673.36716.79379.91-35.39
Tangible Book Value Per Share
11.5512.357.83-7.08
Machinery
3.421.29--
Leasehold Improvements
2.660.86--
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q